Cytosorbents (CTSO) Misses Q1 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
• Morgan Stanley Starts Target Hospitality (TH) at Overweight